Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer. (Q53556189)

15 May 2018

http://europepmc.org/abstract/MED/25839911

title

Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer. (English)

1 reference

15 May 2018

http://europepmc.org/abstract/MED/25839911

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

David Boruta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Rachel M Clark

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

Don S Dizon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

Malinda S Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

Annekathryn Goodman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

John O Schorge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

Marcela G Del Carmen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

Whitfield B Growdon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

1 April 2015

1 reference

15 May 2018

http://europepmc.org/abstract/MED/25839911

published in

Gynecologic Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

volume

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

401-405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Impact of age on survival of patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Rising ovarian cancer mortality in the elderly: a manifestation of differential survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Management of ovarian cancer in patients older than 80 years of Age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Response and outcomes in elderly patients with stages IIIC–IV ovarian cancer receiving platinum–taxane chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Poorer survival of elderly patients with ovarian cancer: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Ovarian cancer in the elderly: impact of surgery on morbidity and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Ovarian cancer in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Chemotherapy in elderly patients with gynecological cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2015.03.052

10.1016/J.YGYNO.2015.03.052

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25839911 AND SRC:MED&resulttype=core&format=json

8 June 2020

1 reference